Suspecting abuse-resistant Oxycontin, buyer kills dealer

In a drug deal gone bad in Boston, the buyer concluded that his source was selling the newer Oxycontin, reformulated to prevent abuse. It wouldn't burn, so it couldn't be smoked. Police suspect that the test failure cost the drug dealer his life. They also suspect that pills were not the reformulated Oxycontin, but rather a fake or a different drug. Article

 

Suggested Articles

CureVac and Tesla are teaming up to produce the German vaccine maker's molecular RNA printers, Tesla CEO Elon Musk tweeted Thursday.

The FDA knocked a California compounding pharmacy facility for a suite of sanitary concerns, including the presence of ants in the plant.

Merck Animal Health will plow $100 million into its DeSoto, Kansas, plant to scale up production of animal vaccines.